0

Journal Articles

in Cardiovascular Disease Prevention
 21-40 of 145 Articles
Invited Commentary |  July 23, 2012
Loneliness and Living Alone:  Comment on “Loneliness in Older Persons” and “Living Alone and Cardiovascular Risk in Outpatients at Risk of or With Atherothrombosis”
Emily M. Bucholz, MPH; Harlan M. Krumholz, MD, SM
Arch Intern Med. 2012;172(14):1084-1085. doi:10.1001/archinternmed.2012.2649.
Original Investigation |  July 23, 2012
Living Alone and Cardiovascular Risk in Outpatients at Risk of or With Atherothrombosis
Jacob A. Udell, MD, MPH; Philippe Gabriel Steg, MD; Benjamin M. Scirica, MD, MPH; et al.
Arch Intern Med. 2012;172(14):1086-1095. doi:10.1001/archinternmed.2012.2782.
Invited Commentary |  June 25, 2012
Statins Work Just as Well in Women as in Men:  Comment on “Statin Therapy in the Prevention of Recurrent Cardiovascular Events”
Fiona Taylor, PhD, HonMFPH; Shah Ebrahim, DM, FRCP
Arch Intern Med. 2012;172(12):919-920. doi:10.1001/archinternmed.2012.2434.
Invited Commentary |  May 14, 2012
Omega-3 Fatty Acids and Secondary Prevention of Cardiovascular Disease—Is It Just a Fish Tale?:  Comment on “Efficacy of Omega-3 Fatty Acid Supplements (Eicosapentaenoic Acid and Docosahexaenoic Acid) in the Secondary Prevention of Cardiovascular Disease”
Frank B. Hu, MD, PhD; JoAnn E. Manson, MD, DrPH
Arch Intern Med. 2012;172(9):694-696. doi:10.1001/archinternmed.2012.463.
Special Article |  April 23, 2012
Cardiovascular Primary Prevention:  How High Should We Set the Bar?
Vinay Prasad, MD; Andrae Vandross, MD
Arch Intern Med. 2012;172(8):656-659. doi:10.1001/archinternmed.2012.812.
Editor's Correspondence |  March 26, 2012
Cardiovascular Risk Evaluation Tools Specific to Population With Diabetes
Justin Basile Echouffo-Tcheugui, MD, PhD; Eugene Sobngwi, MD, PhD; Andre Pascal Kengne, MD, PhD
Arch Intern Med. 2012;172(6):523-524. doi:10.1001/archinternmed.2011.1870.
Editor's Correspondence |  March 26, 2012
Cardiovascular Risk Evaluation Tools Specific to Population With Diabetes—Reply
Nina P. Paynter, PhD; Norman A. Mazer, MD, PhD; Nancy R. Cook, ScD
Arch Intern Med. 2012;172(6):523-524. doi:10.1001/archinternmed.2012.49.
Review Article |  November 14, 2011 FREE
The Effect of Lifestyle Modification and Cardiovascular Risk Factor Reduction on Erectile Dysfunction:  A Systematic Review and Meta-analysis
Bhanu P. Gupta, MD; M. Hassan Murad, MD; Marisa M. Clifton, MD; et al.
Arch Intern Med. 2011;171(20):1797-1803. doi:10.1001/archinternmed.2011.440.
INCLUDES: , Supplemental Content
Invited Commentary |  October 24, 2011
Cardiovascular Risk Stratification, Hemoglobin A1c, and the Tempo of Translation:  Comment on “Cardiovascular Risk Prediction in Diabetic Men and Women Using Hemoglobin A1c vs Diabetes as a High-Risk Equivalent”
Mark J. Pletcher, MD, MPH
Arch Intern Med. 2011;171(19):1718-1720. doi:10.1001/archinternmed.2011.352.
Original Investigation |  October 24, 2011 FREE
Cardiovascular Risk Prediction in Diabetic Men and Women Using Hemoglobin A1c vs Diabetes as a High-Risk Equivalent
Nina P. Paynter, PhD; Norman A. Mazer, MD, PhD; Aruna D. Pradhan, MD; et al.
Arch Intern Med. 2011;171(19):1712-1718. doi:10.1001/archinternmed.2011.351.
INCLUDES: , Supplemental Content
Review Article |  September 12, 2011 FREE
Impact of Pharmacist Care in the Management of Cardiovascular Disease Risk Factors:  A Systematic Review and Meta-analysis of Randomized Trials
Valérie Santschi, PharmD, PhD; Arnaud Chiolero, MD, MSc; Bernard Burnand, MD, MPH; et al.
Arch Intern Med. 2011;171(16):1441-1453. doi:10.1001/archinternmed.2011.399.
Editor's Correspondence |  September 12, 2011
Hypoglycemia Associated With Impaired Renal Function
Adam M. Ali, BA(Cantab)
Arch Intern Med. 2011;171(16):1512. doi:10.1001/archinternmed.2011.378.
Correction |  July 25, 2011
Last-minute Change in June 27 Table of Contents
Arch Intern Med. 2011;171(14):1224. doi:10.1001/archinternmed.2011.366.
Original Investigation |  May 23, 2011 FREE
Effects of Benefits and Harms on Older Persons' Willingness to Take Medication for Primary Cardiovascular Prevention
Terri R. Fried, MD; Mary E. Tinetti, MD; Virginia Towle, MPhil; et al.
Arch Intern Med. 2011;171(10):923-928. doi:10.1001/archinternmed.2011.32.
Invited Commentary |  March 14, 2011
Diabetes and Cardiovascular Risk Equivalency: Do Age at Diagnosis and Disease Duration Affect Risk Stratification?:  Comment on “Impact of Diabetes on Cardiovascular Disease Risk and All-Cause Mortality in Older Men”
Iskandar Idris, DM, FRCP
Arch Intern Med. 2011;171(5):410-411. doi:10.1001/archinternmed.2010.524.
Articles |  February 28, 2011
Error in Wording in: Persistence of Cardiovascular Risk After Rofecoxib Discontinuation
Arch Intern Med. 2011;171(4):305. doi:10.1001/archinternmed.2010.546.
Original Investigation |  February 14, 2011 FREE
Cost-Utility of Aspirin and Proton Pump Inhibitors for Primary Prevention
Stephanie R. Earnshaw, PhD; James Scheiman, MD; A. Mark Fendrick, MD; et al.
Arch Intern Med. 2011;171(3):218-225. doi:10.1001/archinternmed.2010.525.
INCLUDES: , Supplemental Content
Editor's Correspondence |  December 13, 2010
Statins and All-Cause Mortality in High-Risk Primary Prevention of Patients With Cardiovascular Risk Factors
Jasper Jan Brugts, MD, PhD, MSc; Jaap W. Deckers, MD, PhD
Arch Intern Med. 2010;170(22):2041. doi:10.1001/archinternmed.2010.455.
Research Letters |  December 13, 2010 FREE
Persistence of Cardiovascular Risk After Rofecoxib Discontinuation
Joseph S. Ross, MD, MHS; David Madigan, PhD; Marvin A. Konstam, MD; et al.
Arch Intern Med. 2010;170(22):2035-2036. doi:10.1001/archinternmed.2010.461.
Original Investigation |  November 08, 2010 FREE
Effect of an Intensive Exercise Intervention Strategy on Modifiable Cardiovascular Risk Factors in Subjects With Type 2 Diabetes Mellitus:  A Randomized Controlled Trial: The Italian Diabetes and Exercise Study (IDES)
Stefano Balducci, MD; Silvano Zanuso, PhD; Antonio Nicolucci, MD; et al.
Arch Intern Med. 2010;170(20):1794-1803. doi:10.1001/archinternmed.2010.380.
INCLUDES: , Supplemental Content

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA
JAMA Patient Page  |  April 17, 2013
Aspirin Therapy
Janet M. Torpy, MD; Edward H. Livingston, MD
JAMA
Original Contribution  |  April 17, 2013
Prevalence of a Healthy Lifestyle Among Individuals With Cardiovascular Disease in High-, Middle- and Low-Income Countries:  The Prospective Urban Rural Epidemiology (PURE) Study
Koon Teo, MB, PhD; Scott Lear, PhD; Shofiqul Islam, MSc; et al.
JAMA
Viewpoint  |  March 25, 2013
Combination Therapy to Prevent Cardiovascular Disease:  Slow Progress
Richard Smith, MB, ChB, MSc, FRCPE; Tara McCready, MBA, PhD; Salim Yusuf, DPhil, FRCPC, FRSC
JAMA
JAMA Patient Page  |  April 03, 2013
Statins
Deborah Tolmach Sugerman, MSW; Edward H. Livingston, MD; Cassio Lynm, MA
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems